- Home
- NBTX vs BV Comparison
NBTX vs BV Comparison
Compare NBTX & BV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- BV
- Stock Information
- Founded
- NBTX 2003
- BV 1939
- Country
- NBTX France
- BV United States
- Employees
- NBTX N/A
- BV N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- BV Business Services
- Sector
- NBTX Health Care
- BV Consumer Discretionary
- Exchange
- NBTX Nasdaq
- BV Nasdaq
- Market Cap
- NBTX 1.3B
- BV 1.2B
- IPO Year
- NBTX 2020
- BV 2018
- Fundamental
- Price
- NBTX $21.69
- BV $11.89
- Analyst Decision
- NBTX Strong Buy
- BV Buy
- Analyst Count
- NBTX 1
- BV 6
- Target Price
- NBTX $8.00
- BV $17.98
- AVG Volume (30 Days)
- NBTX 99.0K
- BV 729.5K
- Earning Date
- NBTX 09-30-2025
- BV 11-19-2025
- Dividend Yield
- NBTX N/A
- BV N/A
- EPS Growth
- NBTX N/A
- BV N/A
- EPS
- NBTX N/A
- BV 0.12
- Revenue
- NBTX $11,930,711.00
- BV $2,698,700,000.00
- Revenue This Year
- NBTX N/A
- BV $0.10
- Revenue Next Year
- NBTX $122.94
- BV $2.09
- P/E Ratio
- NBTX N/A
- BV $98.54
- Revenue Growth
- NBTX N/A
- BV N/A
- 52 Week Low
- NBTX $2.76
- BV $11.71
- 52 Week High
- NBTX $30.35
- BV $18.08
- Technical
- Relative Strength Index (RSI)
- NBTX 53.91
- BV 36.86
- Support Level
- NBTX $19.90
- BV $12.10
- Resistance Level
- NBTX $23.56
- BV $12.50
- Average True Range (ATR)
- NBTX 1.39
- BV 0.29
- MACD
- NBTX 0.06
- BV 0.01
- Stochastic Oscillator
- NBTX 69.36
- BV 21.59
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About BV BrightView Holdings Inc.
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.